Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Go back to Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus
Marina Biotech, Inc. (NASDAQ: MRNA) Delayed: 245.81 --0 (-0%)
Previous Close $245.81    52 Week High $0.52 
Open $245.81    52 Week Low $0.08 
Day High $245.81    P/E N/A 
Day Low $245.81    EPS $-3.80 
Volume 138,741